| PBYI Stock Yearly Return 2019 Table | ||||||||||||||||||||||||||||||
PBYI average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare PBYI average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| PBYI Share Performance |
| PBYI Stock Yearly Return 2019 Chart | |||
Also see: • PBYI stock yearly return 2020 • PBYI YTD return • PBYI average annual return 10 years | |||
| About Puma Biotechnology Inc |
| Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to improve cancer care. Co. in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Co. is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers. The PBYI stock yearly return is shown above.
The yearly return on the PBYI stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the PBYI annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| PBYI Current Stock Quote |
Get Free SEC filing alerts for PBYI:
PBYI SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Puma Biotechnology (PBYI) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
PCRX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!